Nuvance Health, formerly the Western Connecticut Health network, a regional network of hospitals, includes Danbury and Norwalk Hospital. A clinical trial is now available at these facilities for patients battling advanced-stage cancer who happen to also have a KRAS G12C mutation. These two trial site locations are the only ones in all of Fairfield County. A clinical trial at Danbury Hospital seeks patients with advanced metastatic non-small cell lung cancer (NSCLC) while the Norwalk Hospital study seeks those patients diagnosed with select solid tumors including advanced colorectal cancer (colon cancer).
TrialSite supports clinical research transparency and accessibility with the aim of advancing biomedical research and overall human health. TrialSite offers a brief breakdown of this study, the investigational product, the trial sites and investigators.
This clinical trial is testing an investigational drug called AMG 510 (Sotorosib). Now under development by Amgen, the investigational drug product know as AMG 510 is called Sotorasib (pINN) and targets the specific mutation called G12c in the protein KRAS. As it turns out, this mutation is responsible for a number...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).